Showing results (501-510 of 611) with videos related to

Sort By:
Pageof 62
Journal of Medicinal Chemistry|February 22, 2023
Optimization of 2,3-Dihydroquinazolinone-3-carboxamides as Antimalarials Targeting PfATP4Trent D Ashton, Madeline G Dans, Paola Favuzza, et al.
Psychological Medicine|December 27, 2024
A feasibility randomized controlled trial of an individually delivered, peer support intervention to reduce the impact of psychosis stigma and discrimination for people with psychosis: the let's talk studyMelissa Pyle, Patrick W Corrigan, Lisa Wood, et al.
The Lancet. Psychiatry|July 14, 2018
Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trialAnthony P Morrison, Melissa Pyle, Andrew Gumley, et al.
BMC Psychiatry|August 7, 2016
Design and protocol for the Focusing on Clozapine Unresponsive Symptoms (FOCUS) trial: a randomised controlled trialMelissa Pyle, John Norrie, Matthias Schwannauer, et al.
Lancet (London, England)|February 11, 2014
Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trialAnthony P Morrison, Douglas Turkington, Melissa Pyle, et al.
European Journal of Medicinal Chemistry|July 18, 2024
Optimization of pyrazolopyridine 4-carboxamides with potent antimalarial activity for which resistance is associated with the P. falciparum transporter ABCI3Petar P S Calic, Trent D Ashton, Mahta Mansouri, et al.
Journal of Mental Health (Abingdon, England)|December 23, 2017
Delivery of cognitive-behaviour therapy for psychosis: a service user preference trialGillian Haddock, Katherine Berry, Gabriel Davies, et al.
The Lancet. Psychiatry|April 2, 2018
Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility studyAnthony P Morrison, Heather Law, Lucy Carter, et al.
Health Technology Assessment (Winchester, England)|January 26, 2021
Psychological intervention, antipsychotic medication or a combined treatment for adolescents with a first episode of psychosis: the MAPS feasibility three-arm RCTAnthony P Morrison, Melissa Pyle, Rory Byrne, et al.
BMJ (Clinical Research Ed.)|April 12, 2012
Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trialAnthony P Morrison, Paul French, Suzanne L K Stewart, et al.
Pageof 62